Xorel 20 mg (Tablet (Enteric Coated))
Unit Price: ৳ 4.00 (10 x 10: ৳ 400.00)
Strip Price: ৳ 40.00
Medicine Details
Category | Details |
---|---|
Generic | Rabeprazole sodium |
Company | Ibn sina pharmaceuticals ltd |
Also available as |
Title
- Xorel Gastro-resistant Tablets
Categories
- Medicine
- Gastrointestinal
- Pharmaceutical
Indications
- Treatment of active duodenal ulcer
- Treatment of active benign gastric ulcer
- Treatment of erosive or ulcerative gastro-esophageal reflux disease (GERD)
- Long-term management of gastro-esophageal reflux disease (GERD maintenance)
- Symptomatic treatment of moderate to very severe gastro-esophageal reflux disease (symptomatic GERD)
- Treatment of Zollinger-Ellison Syndrome
- Eradication of Helicobacter pylori in patients with peptic ulcer disease
Mode of Action
- Suppresses gastric acid secretion by inhibiting the gastric H+/K+-ATPase
- Characterized as a gastric proton-pump inhibitor
Dosage
- Recommended oral dose for active duodenal ulcer and active benign gastric ulcer is 20 mg once daily in the morning
- Recommended oral dose for erosive or ulcerative gastro-esophageal reflux disease (GERD) is 20 mg once daily for four to eight weeks
- Maintenance dose of 20 mg or 10 mg once daily for long-term management of gastro-esophageal reflux disease (GERD maintenance)
- 10 mg once daily for symptomatic treatment of moderate to very severe gastro-esophageal reflux disease (symptomatic GERD)
- 5 mg once daily for pediatric patients 1-11 years of age (less than 15 kg)
- 10 mg once daily for pediatric patients 1-11 years of age (15 kg or more)
- Recommended adult starting dose for Zollinger-Ellison Syndrome is 60 mg once a day, titrated upwards to 120 mg/day based on individual patient needs
- Combination therapy for H. pylori eradication: Rabeprazole sodium 20 mg twice daily, clarithromycin 500 mg twice daily, and amoxicillin 1g twice daily for 7 days
Administration
- Should be taken in the morning, before eating
- Tablets should not be chewed or crushed, but should be swallowed whole
Interactions
- May interact with compounds whose absorption is pH dependent
- Co-administration with ketoconazole or itraconazole may decrease antifungal plasma levels
- No interaction with liquid antacids observed
- PPIs, including rabeprazole, should not be co-administered with atazanavir
Contraindications
- Hypersensitivity to the active substance or any excipients
- Contra-indicated in pregnancy and during breastfeeding
Side Effects
- Well-tolerated in both short-term and long-term studies
- May cause headache, diarrhea, abdominal pain, vomiting, constipation, dry mouth, changes in appetite, muscle pain, drowsiness, dizziness
Pregnancy & Lactation
- US FDA pregnancy category 'C'
- No adequate and well-controlled studies in pregnant women
- Likely to be excreted in human milk
Precautions & Warnings
- Symptomatic response does not preclude the presence of gastric or esophageal malignancy
- Patients on long-term treatment should be kept under regular surveillance
- Proton pump inhibitors may modestly increase the risk of hip, wrist, and spine fracture
- Risk of cross-hypersensitivity reactions with other proton pump inhibitors or substituted benzimidazoles
- Reports of blood dyscrasias and hepatic enzyme abnormalities
- Caution in patients with severe hepatic dysfunction
- Co-administration with atazanavir not recommended
- Possible increase in the risk of gastrointestinal infections
- Risk of severe hypomagnesemia after prolonged treatment
- Potential reduction in vitamin B12 absorption
- Rare cases of subacute cutaneous lupus erythematosus associated with PPIs
- Potential interference with laboratory tests, including increased Chromogranin A level
Use in Special Populations
- No dosage adjustment necessary for patients with renal or hepatic impairment
- Not recommended for use in children due to lack of data on safety and efficacy
Overdose Effects
- Effects generally minimal, representative of the known adverse event profile and reversible without further medical intervention
- No specific antidote known
- Extensively protein bound and not dialysable
- Treatment should be symptomatic and general supportive measures should be utilized
Therapeutic Class
- Proton Pump Inhibitor
Storage Conditions
- Keep below 30°C temperature, away from light & moisture
- Keep out of the reach of children
Chemical Structure
- Molecular Formula: C18H21N3O3S
Commonly Asked Questions
- What is Xorel 20 mg Tablet?
- What is Xorel 20 mg Tablet used for?
- What are the side effects of Xorel 20 mg Tablet?
- How should I take Xorel 20 mg Tablet?
- Can I take Xorel 20 mg Tablet while pregnant or breastfeeding?
- What should I do if I overdose on Xorel 20 mg Tablet?
- How long should I take Xorel 20 mg Tablet?
- Is there anything else I should know about Xorel 20 mg Tablet?
- Does Xorel 20 mg Tablet cause bone problems?
- Can I take Xorel 20 mg Tablet with vitamin D?
- Quick Tips
Related Brands
- Xorel 20 mg (Capsule (Enteric Coated)) - ibn-sina-pharmaceuticals-ltd
- Rasonix 20 mg (Capsule (Enteric Coated)) - incepta-pharmaceuticals-ltd
- Rasonix JR 10 mg (Sprinkle Capsule) - incepta-pharmaceuticals-ltd
- Rubee 20 mg (Tablet (Enteric Coated)) - kumudini-pharma-ltd
- Raboz 20 mg (Tablet (Enteric Coated)) - leon-pharmaceuticals-ltd